Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingKaiser Permanente MR Neurography Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentKaiser PermanentePolicy N/A

    Clinical Review Criteria Magnetic Resonance Neurography

    Customize your policy alerts

    Sign up for all Kaiser Permanente policy alerts

    Know when Kaiser Permanente releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and authorization review for magnetic resonance neurography for Kaiser Permanente members in Washington, including commercial and Medicare Advantage plans. It establishes coverage criteria, documentation requirements, and applicable billing guidance for providers.

    Policy Summary
    PayerKaiser Permanente
    PolicyClinical Review Criteria Magnetic Resonance Neurography
    Policy CodePolicy N/A
    Change TypeMaterial revision
    Effective DateDecember 1, 2026
    Last ReviewJul 7, 2026
    Next Review DateN/A
    Key ActionEffective December 1, 2026, use MCG Neurography A-1093 for medical necessity determinations and review magnetic resonance neurography for high-end imaging site of care.
    SourceLink
    POLICY UPDATE CHANGES

    Effective December 1, 2026, Kaiser Permanente adopted MCG Neurography guideline A-1093 for magnetic resonance neurography medical necessity determinations.

    Effective December 1, 2026, inflammatory demyelinating neuropathy is not covered under the adopted MCG guideline, while plexopathy and peripheral nerve tumors are reviewed case by case.

    3Listed clinical indications or indication categories
    Not coveredInflammatory demyelinating neuropathy
    Case-by-case

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Plexopathy and peripheral nerve tumors
    6 monthsClinical notes required
    76498Applicable procedure code

    Medical Necessity Coverage Criteria

    Plexopathy and Peripheral Nerve Tumors

    Effective December 1, 2026.

    Covered or reviewable indication: Magnetic resonance neurography for plexopathy, such as brachial or lumbar plexopathy, or for peripheral nerve tumors will be considered on a case-by-case basis.

    Individual medical necessity review is required.

    Inflammatory Demyelinating Neuropathy

    Effective December 1, 2026.

    Non-covered indication: Magnetic resonance neurography for inflammatory demyelinating neuropathy is not covered under the MCG Neurography A-1093 guideline.

    Kaiser Permanente uses MCG Neurography A-1093 for medical necessity determinations.

    Inflammatory demyelinating neuropathy is not covered under the adopted MCG Neurography A-1093 guideline. Magnetic resonance neurography requests for this indication are therefore not eligible for coverage under the effective December 1, 2026 criteria.

    Applicable Billing Code

    Applicable CPT/HCPCS CodeCPT
    76498Unlisted magnetic resonance procedure (eg, diagnostic, interventional)

    Authorization and Documentation Requirements

    Prior Authorization

    Medical Director Review Required

    Through December 1, 2026, send all magnetic resonance neurography cases for medical director review.

    • Applies to all cases through December 1, 2026.
    Prior Authorization

    MCG and High-End Imaging Review

    Effective December 1, 2026, requests are reviewed for the High-End Imaging Site of Care. Kaiser Permanente has adopted the MCG Neurography, MR A-1093 Care Guideline for medical necessity determinations; refer to that guideline and the applicable review process when submitting requests.

    • Effective December 1, 2026.
    • Medical necessity determinations use MCG Neurography, MR A-1093.

    Magnetic Resonance Neurography

    Magnetic resonance neurography (MRN) is an advanced MRI technique that directly visualizes peripheral nerves using heavily T2-weighted, fat-suppressed sequences. It provides high spatial resolution and contrast to help identify and localize nerve lesions, distinguish intraneural from perineural masses, and assess nerve involvement in trauma, entrapment, tumors, or inflammatory processes.

    Key Definition

    Magnetic resonance neurography
    TechniqueAdvanced MRI technique for direct visualization of peripheral nerves
    Imaging sequencesUses heavily T2-weighted sequences with fat suppression
    Clinical utilityProvides high spatial resolution and contrast to identify and localize nerve lesions, differentiate intraneural from perineural masses, and assess nerve involvement

    Indication Categories

    Plexopathy

    Covered or reviewable when the following indication applies; case-by-case review is required.

    Plexopathy: Magnetic resonance neurography for plexopathy, including brachial or lumbar plexopathy, may be considered on a case-by-case basis.

    Case-by-case medical necessity review is required.

    Peripheral Nerve Tumors

    Covered or reviewable when the following indication applies; case-by-case review is required.

    Peripheral nerve tumors: Magnetic resonance neurography for peripheral nerve tumors may be considered on a case-by-case basis.

    Case-by-case medical necessity review is required.

    Inflammatory Demyelinating Neuropathy

    This indication is not covered under the adopted MCG guideline.

    Prior Authorization Transition

    Prior Authorization

    Prior authorization: medical director review

    Until December 1, 2026, all magnetic resonance neurography cases require medical director review.

    Non-Covered Indication

    Magnetic resonance neurography for inflammatory demyelinating neuropathy is not covered under the adopted MCG Neurography A-1093 guideline.

    Policy Summary
    PayerKaiser Permanente
    PolicyClinical Review Criteria Magnetic Resonance Neurography
    Policy CodePolicy N/A
    Change TypeMaterial revision
    Effective DateDecember 1, 2026
    Last ReviewJul 7, 2026
    Next Review DateN/A
    Key ActionEffective December 1, 2026, use MCG Neurography A-1093 for medical necessity determinations and review magnetic resonance neurography for high-end imaging site of care.
    SourceLink
    On This Page
    Medical Necessity Coverage CriteriaApplicable Billing CodeAuthorization and Documentation RequirementsMagnetic Resonance NeurographyKey DefinitionIndication CategoriesPrior Authorization TransitionNon-Covered Indication
    Documentation Required

    Six Months of Clinical Notes Required

    For covered criteria, submit documentation supporting medical necessity with the request.

    • Provide the last 6 months of clinical notes from the requesting provider and/or specialist.
    Denial Risk

    Inflammatory Demyelinating Neuropathy Not Covered

    Inflammatory demyelinating neuropathy is not covered under the adopted MCG Neurography, MR A-1093 guideline.

    • Coverage determinations must follow the applicable MCG guideline.
    Note

    Case-by-Case Indications

    Requests for plexopathy or peripheral nerve tumors are considered individually and are not automatically covered. Medical necessity must be reviewed for each case.

    • Plexopathy, including brachial or lumbar plexopathy, is reviewed case by case.
    • Peripheral nerve tumors are reviewed case by case.
    Inflammatory demyelinating neuropathy: Magnetic resonance neurography for inflammatory demyelinating neuropathy is not covered under MCG Neurography A-1093.

    Not a covered indication under the criteria effective December 1, 2026.